Brief: Artelo Biosciences Announces Positive Interim Phase 2 Cares Results For The Treatment Of Cancer Anorexia-Cachexia Syndrome (Cacs)
03/09/2025 13:55
Sept 3 (Reuters) - Artelo Biosciences Inc ARTL.O: ARTELO BIOSCIENCES ANNOUNCES POSITIVE INTERIM PHASE 2 CARES RESULTS FOR THE TREATMENT OF CANCER ANOREXIA-CACHEXIA SYNDROME (CACS) ARTELO BIOSCIENCES INC - +6.4% WEIGHT GAIN AT 12 WEEKS VERSUS −5.4% LOSS ON PLACEBO IN INTERIM PHASE 2 CARES STUDY ARTELO BIOSCIENCES INC - SAFETY RESULTS SHOW ART27.13 WELL TOLERATED Source text: ID:nGNX9CjQMT Further company coverage: ARTL.O ((Reuters.Briefs@thomsonreuters.com;))